LAWRENCE BLATT - 10 Mar 2025 SCHEDULE 13D/A Report for Aligos Therapeutics, Inc. Common Stock, par value $0.0001 per share (ALGS)

Filing Manager: LAWRENCE BLATT
Reporting Manager: Lawrence M. Blatt, Ph.D.
Security: Aligos Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: ALGS
Shares outstanding: 5.48M shares
Disclosed Ownership: 176K shares
Ownership: 3.2%
Form type: SCHEDULE 13D/A
Filing time: 12 Mar 2025, 20:30:02 UTC
Date of event: 10 Mar 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Lawrence M. Blatt, Ph.D.	3.2%	176K	176K	0	/s/ Lawrence M. Blatt	Lawrence M. Blatt, Ph.D.	0001242110